Skip to main content
Log in

Management of Anticoagulation and Colonoscopy

  • Colon (JC Anderson, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

A Correction to this article was published on 29 December 2021

This article has been updated

Abstract

Purpose of review

Patients undergoing colonoscopy frequently require antithrombotic therapy for underlying cardiovascular disease. Antithrombotic therapy increases the risk of bleeding during or after colonoscopy, particularly when more invasive procedures are required. However, the risk of thrombosis—with possibly devastating consequences—is increased if antithrombotic agents are held. This review will highlight existing data on the balance of procedural and patient risk factors to guide endoscopists on the management of periprocedural antithrombotic therapy.

Recent findings

Diagnostic colonoscopy has long been established to be low risk for hemorrhage even in patients on antithrombotic therapy, while colonoscopy with interventions—including polypectomy—is viewed as high risk requiring interruption of antithrombotic therapy when possible. Recent data, however, has challenged these practices and suggests that a more nuanced perspective may be necessary. For example, a recent randomly controlled trial found no difference in immediate or delayed hemorrhage between patients on dual antiplatelet therapy versus aspirin and placebo after polypectomy. Further, increasing data are emerging to suggest that small polypectomy (< 1 cm) is safe without interruption of anticoagulation with the use of cold snare polypectomy.

Summary

In patients undergoing colonoscopy, the risk of hemorrhage must be weighed against the risk of thrombosis in patients with cardiovascular disease on antithrombotic agents. In general, low-risk procedures do not require interruption of antithrombotic agents, while high-risk procedures in low-risk patients require holding antithrombotic therapy. High-risk procedures in high-risk patients require individualized decision-making with increasing data helping to support which procedures can safely be performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Change history

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Acosta RD, Abraham NS, Chandrasekhara V, Chathadi KV, Early DS, Eloubeidi MA, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016;83(1):3–16.

    Article  PubMed  Google Scholar 

  2. Veitch AM, Vanbiervliet G, Gershlick AH, Boustiere C, Baglin TP, Smith LA, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Endoscopy. 2016;48(4):c1.

    PubMed  Google Scholar 

  3. Chan FKL, Goh KL, Reddy N, Fujimoto K, Ho KY, Hokimoto S, et al. Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines. Gut. 2018;67(3):405–17.

    Article  CAS  PubMed  Google Scholar 

  4. Timothy SK, Hicks TC, Opelka FG, Timmcke AE, Beck DE. Colonoscopy in the patient requiring anticoagulation. Dis Colon Rectum. 2001;44(12):1845–8 discussion, 8–9.

    Article  CAS  PubMed  Google Scholar 

  5. Hui AJ, Wong RM, Ching JY, Hung LC, Chung SC, Sung JJ. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc. 2004;59(1):44–8.

    Article  PubMed  Google Scholar 

  6. Kim SY, Kim HS, Park HJ. Adverse events related to colonoscopy: global trends and future challenges. World J Gastroenterol. 2019;25(2):190–204.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Macrae FA, Tan KG, Williams CB. Towards safer colonoscopy: a report on the complications of 5000 diagnostic or therapeutic colonoscopies. Gut. 1983;24(5):376–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Rogers BH, Silvis SE, Nebel OT, Sugawa C, Mandelstam P. Complications of flexible fiberoptic colonoscopy and polypectomy. Gastrointest Endosc. 1975;22(2):73–7.

    Article  CAS  PubMed  Google Scholar 

  9. Gavin DR, Valori RM, Anderson JT, Donnelly MT, Williams JG, Swarbrick ET. The national colonoscopy audit: a nationwide assessment of the quality and safety of colonoscopy in the UK. Gut. 2013;62(2):242–9.

    Article  PubMed  Google Scholar 

  10. Wexner SD, Garbus JE, Singh JJ. A prospective analysis of 13,580 colonoscopies. Reevaluation of credentialing guidelines. Surg Endosc. 2001;15(3):251–61.

    Article  CAS  PubMed  Google Scholar 

  11. Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish atrial fibrillation cohort study. Eur Heart J. 2012;33(12):1500–10.

    Article  PubMed  Google Scholar 

  12. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S–e50S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. Jama. 2013;310(14):1462–72.

    Article  CAS  PubMed  Google Scholar 

  14. Patrono C. Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective. Br J Clin Pharmacol. 2016;82(4):957–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Nelson DB, Freeman ML. Major hemorrhage from endoscopic sphincterotomy: risk factor analysis. J Clin Gastroenterol. 1994;19(4):283–7.

    Article  CAS  PubMed  Google Scholar 

  16. Shiffman ML, Farrel MT, Yee YS. Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS. Gastrointest Endosc. 1994;40(4):458–62.

    Article  CAS  PubMed  Google Scholar 

  17. Yousfi M, Gostout CJ, Baron TH, Hernandez JL, Keate R, Fleischer DE, et al. Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol. 2004;99(9):1785–9.

    Article  PubMed  Google Scholar 

  18. • Pigò F, Bertani H, Grande G, Abate F, Vavassori S, Conigliaro RL. Post-polypectomy bleeding after colonoscopy on uninterrupted aspirin/non steroideal antiflammatory drugs: systematic review and meta-analysis. Dig Liver Dis. 2018;50(1):20–6. Large meta-analysis demonstrating the safety of aspirin in regards to low risk of post polypectomy bleeding.

    Article  PubMed  Google Scholar 

  19. Metz AJ, Bourke MJ, Moss A, Williams SJ, Swan MP, Byth K. Factors that predict bleeding following endoscopic mucosal resection of large colonic lesions. Endoscopy. 2011;43(6):506–11.

    Article  CAS  PubMed  Google Scholar 

  20. Burgess NG, Metz AJ, Williams SJ, Singh R, Tam W, Hourigan LF, et al. Risk factors for intraprocedural and clinically significant delayed bleeding after wide-field endoscopic mucosal resection of large colonic lesions. Clin Gastroenterol Hepatol. 2014;12(4):651–61.e1–3.

    Article  PubMed  Google Scholar 

  21. Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27(22):2667–74.

    Article  PubMed  Google Scholar 

  22. Feagins LA. Colonoscopy, polypectomy, and the risk of bleeding. Med Clin North Am. 2019;103(1):125–35.

    Article  PubMed  Google Scholar 

  23. Singh M, Mehta N, Murthy UK, Kaul V, Arif A, Newman N. Postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel therapy. Gastrointest Endosc. 2010;71(6):998–1005.

    Article  PubMed  Google Scholar 

  24. Feagins LA, Iqbal R, Harford WV, Halai A, Cryer BL, Dunbar KB, et al. Low rate of postpolypectomy bleeding among patients who continue thienopyridine therapy during colonoscopy. Clin Gastroenterol Hepatol. 2013;11(10):1325–32.

    Article  PubMed  Google Scholar 

  25. • Chan FKL, Kyaw MH, Hsiang JC, Suen BY, Kee KM, Tse YK, et al. Risk of postpolypectomy bleeding with uninterrupted clopidogrel therapy in an industry-independent, double-blind, randomized trial. Gastroenterology. 2019;156(4):918–25.e1. First study to suggest that continuation of clopidogrel in patients on DAPT does not increase the risk of immediate or delayed post polypectomy bleeding.

    Article  CAS  PubMed  Google Scholar 

  26. Squizzato A, Bellesini M, Takeda A, Middeldorp S, Donadini MP. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;12(12):Cd005158.

    PubMed  Google Scholar 

  27. Eisenberg MJ, Richard PR, Libersan D, Filion KB. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation. 2009;119(12):1634–42.

    Article  CAS  PubMed  Google Scholar 

  28. Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373(9):823–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Inoue T, Nishida T, Maekawa A, Tsujii Y, Akasaka T, Kato M, et al. Clinical features of post-polypectomy bleeding associated with heparin bridge therapy. Dig Endosc. 2014;26(2):243–9.

    Article  PubMed  Google Scholar 

  30. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e152S–e84S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Desai J, Kolb JM, Weitz JI, Aisenberg J. Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies. Thromb Haemost. 2013;110(2):205–12.

    Article  CAS  PubMed  Google Scholar 

  32. Dunn A. Perioperative management of oral anticoagulation: when and how to bridge. J Thromb Thrombolysis. 2006;21(1):85–9.

    Article  PubMed  Google Scholar 

  33. Douketis JD, Healey JS, Brueckmann M, Eikelboom JW, Ezekowitz MD, Fraessdorf M, et al. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost. 2015;113(3):625–32.

    Article  PubMed  Google Scholar 

  34. Khadzhynov D, Wagner F, Formella S, Wiegert E, Moschetti V, Slowinski T, et al. Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease. Thromb Haemost. 2013;109(4):596–605.

    Article  CAS  PubMed  Google Scholar 

  35. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124(14):1573–9.

    Article  CAS  PubMed  Google Scholar 

  36. Sorbi D, Norton I, Conio M, Balm R, Zinsmeister A, Gostout CJ. Postpolypectomy lower GI bleeding: descriptive analysis. Gastrointest Endosc. 2000;51(6):690–6.

    Article  CAS  PubMed  Google Scholar 

  37. Reumkens A, Rondagh EJ, Bakker CM, Winkens B, Masclee AA, Sanduleanu S. Post-colonoscopy complications: a systematic review, time trends, and meta-analysis of population-based studies. Am J Gastroenterol. 2016;111(8):1092–101.

    Article  PubMed  Google Scholar 

  38. Friedland S, Sedehi D, Soetikno R. Colonoscopic polypectomy in anticoagulated patients. World J Gastroenterol. 2009;15(16):1973–6.

    Article  PubMed  PubMed Central  Google Scholar 

  39. •• Horiuchi A, Nakayama Y, Kajiyama M, Tanaka N, Sano K, Graham DY. Removal of small colorectal polyps in anticoagulated patients: a prospective randomized comparison of cold snare and conventional polypectomy. Gastrointest Endosc. 2014;79(3):417–23. The first randomized trial to demonstrate the significant decrease in delayed bleeding hemorrhage for cold snare in comparison to hot snare polypectomy in patients on anticoagulation.

    Article  PubMed  Google Scholar 

  40. •• Takeuchi Y, Mabe K, Shimodate Y, Yoshii S, Yamada S, Iwatate M, et al. Continuous anticoagulation and cold snare polypectomy versus heparin bridging and hot snare polypectomy in patients on anticoagulants with subcentimeter polyps: a randomized controlled trial. Ann Intern Med. 2019;171(4):229–37. The first randomized trial to demonstrate the non-inferiority of cold snare polypectomy with continued anticoagulation versus bridging therapy with hot snare polypectomy for small polyps.

    Article  PubMed  Google Scholar 

  41. Ferlitsch M, Moss A, Hassan C, Bhandari P, Dumonceau JM, Paspatis G, et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2017;49(3):270–97.

    Article  PubMed  Google Scholar 

  42. Zhang QS, Han B, Xu JH, Gao P, Shen YC. Clip closure of defect after endoscopic resection in patients with larger colorectal tumors decreased the adverse events. Gastrointest Endosc. 2015;82(5):904–9.

    Article  PubMed  Google Scholar 

  43. • Pohl H, Grimm IS, Moyer MT, Hasan MK, Pleskow D, Elmunzer BJ, et al. Clip closure prevents bleeding after endoscopic resection of large colon polyps in a randomized trial. Gastroenterology. 2019;157(4):977–84.e3. Study redomonstrating that post polypectomy clipping after large polyp removal is beneficial but predominantly in the right colon.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael O’Donnell MD, MBA.

Ethics declarations

Conflict of interest

Michael O’Donnell declares that he has no conflict of interest. Seth A. Gross declares that he has no conflict of interest.

Human and animal rights

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Colon

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Donnell, M., Gross, S.A. Management of Anticoagulation and Colonoscopy. Curr Treat Options Gastro 19, 1–13 (2021). https://doi.org/10.1007/s11938-020-00331-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-020-00331-w

Keywords

Navigation